Ming-Tsung Lai Selected Research

Ming-Tsung Lai Research Topics

Disease

17	Neoplasms (Cancer) 01/2024 - 08/2002
6	Endometriosis 01/2022 - 01/2013
5	Carcinoma (Carcinomatosis) 11/2016 - 08/2002
3	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 03/2013
3	Prostatic Neoplasms (Prostate Cancer) 03/2008 - 01/2005
2	Infertility (Sterility) 01/2022 - 08/2015
2	Carcinogenesis 12/2020 - 11/2002
2	Squamous Cell Carcinoma of Head and Neck 01/2019 - 03/2009
1	Colorectal Neoplasms (Colorectal Cancer) 01/2024
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 02/2017
1	Ascites 02/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2014
1	Leukemia 01/2014
1	Osteosarcoma (Osteogenic Sarcoma) 01/2014
1	Adenocarcinoma 12/2013
1	Lung Neoplasms (Lung Cancer) 12/2013
1	Urolithiasis 12/2012
1	Mouth Neoplasms (Oral Cancer) 03/2009
1	Poisoning 02/2009
1	Necrosis 02/2009
1	Acute Liver Failure (Fulminant Hepatic Failure) 02/2009
1	Neoplasm Metastasis (Metastasis) 03/2008
1	Nephrocalcinosis 02/2008

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 12/2022 - 03/2008
3	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2013
3	Cadherins (E-Cadherin)IBA 12/2020 - 01/2005
2	RNA Polymerase I (Polymerase I, RNA)IBA 01/2022 - 11/2016
2	Long Noncoding RNAIBA 01/2022 - 01/2021
2	Ethylene Glycol (Monoethylene Glycol)IBA 12/2012 - 02/2008
2	Proline-Directed Protein KinasesIBA 11/2002 - 08/2002
1	tocilizumab (atlizumab)FDA Link 01/2024
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2024
1	CateninsIBA 12/2022
1	CX 5461IBA 01/2022
1	omipalisibIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2021
1	CaspasesIBA 01/2019
1	Keratins (Keratin)IBA 01/2019
1	LuciferasesIBA 02/2017
1	evodiamineIBA 02/2017
1	Zuo-Jin-WanIBA 02/2017
1	BerberineIBA 02/2017
1	AlkaloidsIBA 02/2017
1	Ribosomal Proteins (Ribosomal Protein)IBA 11/2016
1	MucinsIBA 08/2015
1	AntigensIBA 08/2015
1	Oncogene Proteins (Oncogene Protein)IBA 06/2014
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2014
1	Cytochromes c (Cytochrome c)IBA 01/2014
1	FlavanonesIBA 01/2014
1	2'-hydroxyflavanoneIBA 01/2014
1	Peptide Hydrolases (Proteases)FDA Link 12/2013
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 12/2013
1	PhytochemicalsIBA 12/2013
1	Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA 12/2013
1	PaxillinIBA 12/2013
1	Kruppel-Like Factor 4IBA 12/2013
1	CyclinsIBA 03/2013
1	ChromatinIBA 03/2013
1	Carthamus tinctorius Honghua extractIBA 12/2012
1	ErbB Receptors (EGF Receptor)IBA 03/2009
1	DNA (Deoxyribonucleic Acid)IBA 03/2009
1	RTKI cpdIBA 03/2009
1	Glutathione (Reduced Glutathione)IBA 02/2009
1	Acetaminophen (Paracetamol)FDA LinkGeneric 02/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2009
1	romidepsin (FK228)FDA Link 03/2008
1	Prostate-Specific Antigen (Semenogelase)IBA 03/2008
1	DepsipeptidesIBA 03/2008
1	wulingsanIBA 02/2008
1	EnzymesIBA 07/2005
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 07/2005
1	glutathione S-transferase M1IBA 07/2005
1	Insulin (Novolin)FDA Link 07/2005
1	Epidermal Growth Factor (EGF)IBA 07/2005
1	Genetic Markers (Genetic Marker)IBA 07/2005
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2005
1	Bleomycin (Blenoxane)FDA LinkGeneric 08/2002
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2002
1	Vinblastine (Vinblastine Sulfate)FDA Link 08/2002
1	Vincristine (Oncovin)FDA LinkGeneric 08/2002

Therapy/Procedure

4	Therapeutics 01/2024 - 03/2009
2	Oral Administration 02/2017 - 03/2008
1	Precision Medicine 01/2024
1	Aftercare (After-Treatment) 03/2018
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2017
1	Drug Therapy (Chemotherapy) 11/2002